Latest SEC Filings

Fluent, Inc.Fluent, Inc. Reports 8% Revenue Growth in Q2 2026, Net Loss Improves

BOSTON OMAHA CorpBoston Omaha Corporation Reports Q2 2026 Revenue Growth to $22.2 Million Despite Net Loss

Embassy Bancorp, Inc.Embassy Bancorp Reports 20% Increase in Net Income for Q2 2026

WhiteHawk Minerals Corp.WhiteHawk Minerals Reports 37.9% Revenue Growth and $39.2 Million Net Loss in Latest Quarter

Idea Acquisition Corp.Idea Acquisition Corp. Reports $2.85 Million Net Income for Quarter Ending June 30, 2026

Horizon Space Acquisition I Corp.Horizon Space Acquisition I Corp. Reports $90,586 Net Loss for Quarter Ending June 30, 2026

Roadzen Inc.Roadzen Inc. Reports 49% Revenue Growth to $16.2 Million Despite Increased Net Loss

Health In Tech, Inc.Health In Tech, Inc. Reports $8.1 Million Revenue and $2.5 Million Net Loss for Q2 2026

Kraig Biocraft Laboratories, IncKraig Biocraft Laboratories Reports Increased Net Loss and Rising Operating Expenses in Q2 2026

NextBoat Inc.NextBoat Inc. Reports 88.4% Revenue Growth in Q2 2026 Despite Net Loss

ChampionsGate Acquisition CorpChampionsGate Acquisition Corporation Reports Q2 2026 Net Income of $583,350

Lafayette Digital Acquisition Corp. ILafayette Digital Acquisition Corp. I Reports $2.4M Net Income and $293.2M Total Assets as of June 30, 2026

TurnOnGreen, Inc.TurnOnGreen Reports 4% Revenue Growth in Q2 2026, Continues to Face Net Losses

Aspire Biopharma Holdings, Inc.Aspire Biopharma Reports Revenue Growth and Strategic Acquisition in Latest Financial Filing

Cadrenal Therapeutics, Inc.Cadrenal Therapeutics Reports Q2 2026 Financial Results with Reduced Net Loss

Ensysce Biosciences, Inc.Ensysce Biosciences Reports Decrease in Revenue and Increased Net Loss in Latest 10-Q Filing

QUANTUM X LABS INC.Quantum X Labs Reports Revenue Decline and Increased Losses for First Half of 2026

TAO Synergies Inc.TAO Synergies Reports Revenue Surge to $88,626 and Reduced Losses in Q2 2026

Fortress Biotech, Inc.Fortress Biotech Reports 14% Revenue Growth and Net Income Turnaround in Q2 2026

BioXcel Therapeutics, Inc.BioXcel Therapeutics Reports $14.7 Million Net Loss and Advances Neuroscience Pipeline

CAPSTONE COMPANIES, INC.Capstone Companies Reports No Revenue and Significant Losses in Latest 10-Q Filing

Avidia Bancorp, Inc.Avidia Bancorp Reports 85% Increase in Net Income to $7.2 Million for Q2 2026

Miluna Acquisition CorpMiluna Acquisition Corp Reports Improved Financial Results and Pursues Business Combination with Kukugan Invest

LENSAR, Inc.LENSAR Reports 18% Revenue Growth and Net Income Turnaround in Q2 2026

Yale Transaction Finders, Inc.Yale Transaction Finders Reports Increased Net Loss and Rising Operating Expenses for First Half of 2026